Biocon informs about AGM and annul report

Biocon Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532523 | NSE: BIOCON

15 Jul 2026 Evaluate

Further to letter dated May 07, 2026, intimating that the 48th Annual General Meeting (‘AGM’) of the Company will be held on Thursday August 06, 2026 at 3:30 PM (IST) through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’) in compliance with applicable provisions of the Companies Act, 2013 (‘the Act’) and rules made thereunder, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with all applicable circulars on the matter issued by the Ministry of Corporate Affairs (‘MCA’) and the Securities and Exchange Board of India (‘SEBI’) and pursuant to the provisions of Regulation 30 and 34 of the SEBI Listing Regulations, Biocon has informed that it enclosed the Notice of 48th AGM and Integrated Annual Report (BRSR, GRI & ESG Data Book FY26 is a supplement to the Integrated Annual Report) of the Company for the Financial Year 2025-26. The same are also made available on the website of the Company at www.biocon.com. In compliance with the applicable Circulars issued by MCA and SEBI Listing Regulations, the Notice of the 48th AGM along with the Integrated Annual Report for the Financial Year 2025-26 are being sent only through electronic mode to those Members whose e-mail IDs are registered with the Registrar and Share Transfer Agents (‘RTA’) (in case of shares held in physical form) or with Depository Participants (‘DPs’) (in case of shares held in demat form). Further, pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, the Company has also sent letter containing the weblink along with the path and QR Code to access the Notice of the 48th AGM and Integrated Annual Report of the Company for Financial Year 2025-2026, to those Members who have not registered their e-mail IDs with the RTA or with the DPs. Copy of the said letter is enclosed.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

434.65 -2.65 (-0.61%)

15-Jul-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma. Inds.	1952.45
Dr. Reddys Labs.	1229.80
Cipla	1437.95
Zydus Lifesciences	1154.40
Lupin	2491.80
View more..

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.